Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples